Gene | Uniprot | Gene Full Name | Protein Class | pLI | DSI v | DPI v |
---|---|---|---|---|---|---|
MIR320A | microRNA 320a | 0.526 | 0.808 | |||
MIR130A | microRNA 130a | 0.522 | 0.808 | |||
MIR30C2 | microRNA 30c-2 | 0.546 | 0.769 | |||
IFN1@ | interferon, type 1, cluster | 0.565 | 0.731 | |||
MIR30C1 | microRNA 30c-1 | 0.552 | 0.769 | |||
MS | multiple sclerosis | 0.599 | 0.692 | |||
P2RX5-TAX1BP3 | P2RX5-TAX1BP3 readthrough (NMD candidate) | 0.588 | 0.769 | |||
TSBP1-AS1 | TSBP1 and BTNL2 antisense RNA 1 | 0.638 | 0.692 | |||
ZEB1-AS1 | ZEB1 antisense RNA 1 | 0.636 | 0.423 | |||
MAPT-AS1 | MAPT antisense RNA 1 | 0.711 | 0.269 | |||
HLA-DRB9 | major histocompatibility complex, class II, DR beta 9 (pseudogene) | 0.682 | 0.654 | |||
SPRY4-AS1 | SPRY4 antisense RNA 1 | 0.890 | 0.192 | |||
LINC01500 | long intergenic non-protein coding RNA 1500 | 0.760 | 0.192 | |||
HOXD-AS2 | HOXD cluster antisense RNA 2 | 0.780 | 0.269 | |||
TRAJ60 | T cell receptor alpha joining 60 (pseudogene) | 0.751 | 0.346 | |||
CHKB-CPT1B | CHKB-CPT1B readthrough (NMD candidate) | 0.769 | 0.385 | |||
PICSAR | P38 inhibited cutaneous squamous cell carcinoma associated lincRNA | 0.821 | 0.308 | |||
GDNF-AS1 | GDNF antisense RNA 1 | 0.861 | 0.115 | |||
MIR4455 | microRNA 4455 | 0.890 | 0.154 | |||
LINC00964 | long intergenic non-protein coding RNA 964 | 0.839 | 0.269 | |||
LINC02336 | long intergenic non-protein coding RNA 2336 | 0.861 | 0.192 | |||
LINC00163 | long intergenic non-protein coding RNA 163 | 0.861 | 0.154 | |||
LINC01847 | long intergenic non-protein coding RNA 1847 | 0.890 | 0.154 | |||
HLA-F-AS1 | HLA-F antisense RNA 1 | 0.861 | 0.269 | |||
LINC00861 | long intergenic non-protein coding RNA 861 | 0.890 | 0.154 |